Kasabach-Merritt phenomenon (KMP) is a rare consumptive coagulopathy associated with
specific vascular tumors, kaposiform hemangioendothelioma, and tufted angioma …

Vascular tumors are among the most common neoplasms in infants and children; 5%–10%
of newborns present with or develop lesions within the first 3 months of life. Most are benign …

Background Kaposiform haemangioendothelioma (KHE) is a tumor of intermediate
malignant potential derived from vascular endothelial cells. Due to rarity of head neck KHE …

Mammalian target of rapamycin inhibitors have shown promising results in the management
of kaposiform hemangioendothelioma (KHE). The purpose of this study was to present our …

Background Kaposiform hemangioendothelioma (KHE) with Kasabach–Merritt phenomenon
(KMP) still remains a particular and life‐threatening disease. The purpose of this study was …

In this chapter, most of the mesenchymal (soft‐tissue) tumours involving the skin (including
subcutaneous tissue) are described. Practically any soft‐tissue tumour can involve or …

Kasabach–Merritt phenomenon (KMP) is a rare and life‐threatening disease involving a
vascular tumor combined with severe consumptive coagulopathy. We present for the first …

The therapy of complicated Kaposiform hemangioendothelioma (KHE) is still difficult. We
present the first case of laryngomalacia with simultaneous mammalian target of Rapamycin …

Objective To evaluate the outcome and safety of corticosteroids and vincristine (VCR) in the
treatment of kaposiform hemangioendothelioma (KHE) and tufted angioma (TA). Materials …

OBJECTIVE. The purposes of this article are to provide an up-to-date overview of neonatal
soft-tissue tumors, including information regarding their unique nature, and to present …